GlassScriptPhysician profile
Chirag M Pandya
NPI 1891951083
$14,781.56
in general payments reported to CMS, 2019-2025
20 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what 82% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,089 · 2020: $2,710 · 2021: $247 · 2022: $992 · 2023: $636 · 2024: $701 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Long Term Medical Supply Or Device Loan: $636 · Education: $94.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.62 |
| Long Term Medical Supply Or Device Loan | $635.75 |
| Education | $94.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $10,863.07 | 2019-2025 | Ofev, Jascayd |
| Philips North America LLC | $1,754.18 | 2022-2025 | Vest Therapy Und, (8874) Incourage |
| Astrazeneca Pharmaceuticals LP | $516.06 | 2024-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $451.50 | 2024-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Ethicon INC. | $246.56 | 2021 | |
| Pulmonx Corporation | $187.20 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Genzyme Corporation | $160.71 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $94.95 | 2024 | |
| Amgen INC. | $84.36 | 2024-2025 | Tezspire |
| Verona Pharma, INC. | $79.86 | 2025 | Ohtuvayre |
| Insmed, INC. | $68.76 | 2025 | Arikayce |
| Lilly USA, LLC | $55.95 | 2025 | Zepbound |
| Medical Device Business Services, INC. | $53.27 | 2024 | Monarch |
| Jazz Pharmaceuticals INC. | $33.99 | 2024-2025 | |
| Boston Scientific Corporation | $31.08 | 2024 | Acquire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $28.75 | 2025 | Sunosi |
| Baxter Healthcare | $24.61 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Avadel Cns Pharmaceuticals, LLC | $18.14 | 2025 | Lumryz |
| Electromed, INC. | $15.86 | 2024 | Smartvest |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Pandya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.